J1611
HCPCSInj glucagon hcl, fresenius
Official HCPCS Level II long descriptor
Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
HCPCS Level II code J1611 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj glucagon hcl, fresenius
Added to HCPCS: 2023-01-01
Nearby codes in J1
- J1595Injection glatiramer acetate
- J1596Inj, glycopyrrolate, 0.1 mg
- J1597Inj glycopyrrolate, glyrx-pf
- J1598Inj glycopyrrolate fres kabi
- J1599Ivig non-lyophilized, nos
- J1600Gold sodium thiomaleate inj
- J1602Golimumab for iv use 1mg
- J1610Glucagon hydrochloride/1 mg
- J1612Inj glucagon (gvoke) 0.01 mg
- J1626Granisetron hcl injection
- J1627Inj, granisetron, xr, 0.1 mg
- J1628Inj., guselkumab, 1 mg
- J1630Haloperidol injection
- J1631Haloperidol decanoate inj
- J1632Inj., brexanolone, 1 mg
- J1640Hemin, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.